These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1285411)

  • 1. Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506.
    Bavandi A; Meingassner JG; Becker S
    Exp Dermatol; 1992 Nov; 1(4):199-205. PubMed ID: 1285411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypomagnesic rat model: dermatitis-prone hairless rats with mild magnesium depletion fed a diet low in lipids did not develop pruritic dermatitis.
    Thomsen JS; Nielsen PL; Serup J
    Skin Res Technol; 2005 Feb; 11(1):42-6. PubMed ID: 15691258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
    Wakugami T; Islam MR; Higa S; Murakami K; Mimura G
    Tohoku J Exp Med; 1993 Jan; 169(1):21-9. PubMed ID: 7692621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
    Mysliwiec J; Azzadin A; Chabielska E; Takada A; Mysliwiec M; Buczko W
    Thromb Res; 1996 Jul; 83(2):175-81. PubMed ID: 8837316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical FK506--clinical potential or laboratory curiosity?
    Lauerma AI; Maibach HI
    Dermatology; 1994; 188(3):173-6. PubMed ID: 7514460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model.
    McElwee KJ; Rushton DH; Trachy R; Oliver RF
    Br J Dermatol; 1997 Oct; 137(4):491-7. PubMed ID: 9390322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
    Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
    Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs.
    Norris AA; Jackson DM; Eady RP
    Clin Exp Immunol; 1992 Sep; 89(3):347-50. PubMed ID: 1381297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981.
    Neckermann G; Bavandi A; Meingassner JG
    Br J Dermatol; 2000 Apr; 142(4):669-79. PubMed ID: 10792216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
    Woo J; Propper DJ; Macleod AM; Thomson AW
    Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of FK506 and cyclosporin A on antigen-induced arthritis.
    Blackham A; Griffiths RJ
    Clin Exp Immunol; 1991 Nov; 86(2):224-8. PubMed ID: 1718639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation.
    Reis A; Reinhard T; Sundmacher R; Braunstein S; Godehardt E
    Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):785-9. PubMed ID: 9801895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin inflammation induced by hypomagnesaemia in the rat.
    Saurat JH; Chavez P; Ponvert C; Galloppin L
    Br J Dermatol; 1983 Jul; 109 Suppl 25():106-10. PubMed ID: 6860576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
    Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
    Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
    Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporine or FK506 in chronic colitis.
    Aiko S; Conner EM; Fuseler JA; Grisham MB
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1075-84. PubMed ID: 9023326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506.
    Gibson SW; Valente JF; Alexander JW; Custer DA; Li BG; Frede S; Babcock GF; Ogle CK
    Transplantation; 2000 May; 69(10):2034-8. PubMed ID: 10852592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney.
    Yang CW; Ahn HJ; Han HJ; Kim WY; Li C; Shin MJ; Kim SK; Park JH; Kim YS; Moon IS; Bang BK
    Transplantation; 2001 Dec; 72(11):1753-9. PubMed ID: 11740384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.